BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17352218)

  • 1. Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.
    Kaifi JT; Cataldegirmen G; Wachowiak R; Schurr PG; Kleinhans H; Kosti G; Yekebas EF; Mann O; Kutup A; Kalinin V; Strate T; Izbicki JR
    Anticancer Res; 2007; 27(1A):69-73. PubMed ID: 17352218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.
    Kaifi JT; Rawnaq T; Schurr PG; Yekebas EF; Mann O; Merkert P; Link BC; Kalinin V; Pantel K; Sauter G; Strate T; Izbicki JR
    Am J Surg; 2007 Sep; 194(3):380-4. PubMed ID: 17693286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.
    Blessmann M; Kaifi JT; Schurr PG; Cihan A; Kalinin V; Trump F; Atac A; Heiland M; Pohlenz P; Blake F; Schmelzle R; Izbicki JR
    Oral Oncol; 2008 Feb; 44(2):143-7. PubMed ID: 17418617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population.
    Yue CM; Bi MX; Tan W; Deng DJ; Zhang XY; Guo LP; Lin DX; Lu SH
    Int J Cancer; 2004 Jan; 108(2):232-6. PubMed ID: 14639608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between esophageal cancer-related gene 2 polymorphism and esophageal squamous cell carcinomas in Kazakhs and Hans of Xinjiang.
    Gao L; Li J; Zheng Y
    Int J Clin Exp Pathol; 2019; 12(9):3408-3416. PubMed ID: 31934184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.
    Zhang T; Zhao D; Wang Q; Yu X; Cui Y; Guo L; Lu SH
    Mol Carcinog; 2013 Aug; 52(8):581-90. PubMed ID: 22315007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowskal H; Strzelczyk J; Janiak A; Malecka-Panas E
    Hepatogastroenterology; 2006; 53(70):608-12. PubMed ID: 16995472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma.
    Nisevic I; Dinic J; Nikolic A; Djordjevic V; Lukic S; Ugljesic M; Andjelic-Jelic M; Petrovic-Stanojevic N; Radojkovic D
    Cell Biochem Funct; 2008 Aug; 26(6):659-63. PubMed ID: 18636416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ECRG2 TCA short tandem repeat polymorphism with the risk of oesophageal cancer in a North Indian population.
    Jain M; Kumar S; Ghoshal UC; Mittal B
    Clin Exp Med; 2008 Jun; 8(2):73-8. PubMed ID: 18618216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
    Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
    Stocker G; Ott K; Henningsen N; Becker K; Hapfelmeier A; Lordick F; Hois S; Plaschke S; Höfler H; Keller G
    Eur J Cancer; 2009 Dec; 45(18):3326-35. PubMed ID: 19822419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
    Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
    Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis.
    Liu QC; Gao F; Ou QS; Zhuang ZH; Lin SR; Yang B; Cheng ZJ
    Chin Med J (Engl); 2008 Jan; 121(2):108-11. PubMed ID: 18272034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome.
    Navaglia F; Basso D; Fogar P; Sperti C; Greco E; Zambon CF; Stranges A; Falda A; Pizzi S; Parenti A; Pedrazzoli S; Plebani M
    Am J Clin Pathol; 2006 Oct; 126(4):593-601. PubMed ID: 16938655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders.
    Kume K; Masamune A; Takagi Y; Kikuta K; Watanabe T; Satoh K; Satoh A; Hirota M; Hamada S; Shimosegawa T
    Gut; 2009 Jun; 58(6):820-4. PubMed ID: 19052022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
    Crnogorac-Jurcevic T; Gangeswaran R; Bhakta V; Capurso G; Lattimore S; Akada M; Sunamura M; Prime W; Campbell F; Brentnall TA; Costello E; Neoptolemos J; Lemoine NR
    Gastroenterology; 2005 Nov; 129(5):1454-63. PubMed ID: 16285947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer.
    Hengstler JG; Bauer A; Wolf HK; Bulitta CJ; Tanner B; Oesch F; Gebhard S; Boettger T
    Anticancer Res; 2000; 20(5A):2967-74. PubMed ID: 11062709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor microsatellite haplotypes are associated with chronic pancreatitis.
    O'Reilly DA; Dunlop S; Sargen K; Demaine A; Wilkinson S; Kingsnorth AN
    JOP; 2006 Jan; 7(1):14-26. PubMed ID: 16407614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16(INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer.
    Gerdes B; Ramaswamy A; Kersting M; Ernst M; Lang S; Schuermann M; Wild A; Bartsch DK
    Surgery; 2001 Apr; 129(4):490-7. PubMed ID: 11283541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.